Toxicology in Emergency Practice: Common Poisons and Diagnostic Approach

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Toxidrome recognition, a constellation of clinical signs (e.g., miosis, bradycardia in cholinergic toxidrome; hyperthermia, mydriasis in sympathomimetic toxidrome), is foundational for narrowing differential diagnoses in unknown toxic exposures, guiding subsequent diagnostic testing and therapeutic interventions.
• A structured diagnostic approach integrates signalment, a detailed exposure history (including time since exposure and quantity), systematic physical examination findings, and targeted laboratory testing, accounting for significant species-specific metabolic differences (e.g., reduced glucuronidation in cats, ruminal microbial metabolism in ruminants).
• Decontamination decisions (emesis, activated charcoal, gastric lavage) are time-sensitive and risk-dependent, requiring careful patient assessment for airway patency and mentation, with species-specific contraindications and practical considerations (e.g., no emesis in horses/ruminants).
• Laboratory diagnostics should prioritize tests that directly influence acute management, such as blood gas analysis for acid-base status, coagulation profiles for anticoagulant rodenticide suspicion, and specific assays for ethylene glycol or cholinesterase inhibitors, while acknowledging that quantitative toxicology results are often too slow for emergency intervention.
• Serial monitoring of vital parameters (heart rate, rhythm via ECG, blood pressure, blood glucose, renal function, neurologic status) is critical for detecting deterioration and guiding escalation of care, with specific triggers for intervention (e.g., new conduction block, MAP below 60 mmHg, SpO2 below 94%).
• Common errors include anchoring on a single historical clue, performing decontamination before stabilization, failing to recheck laboratory values, and treating the toxin rather than the patient's clinical syndrome, necessitating a differential diagnosis approach and individualized supportive care.

Toxicologic emergencies present a distinct diagnostic challenge in veterinary practice. The patient often arrives with nonspecific signs, an incomplete exposure history, and a narrow therapeutic window for intervention. This article provides a structured framework for the practicing veterinarian facing suspected poisoning, with emphasis on diagnostic reasoning for unknown toxin exposure instead of antidote-specific management. It covers the pathophysiology of common toxicants across species, clinical recognition patterns, diagnostic testing strategies, and decision pathways that guide stabilization and decontamination decisions.

The clinical question this article answers is direct: when a patient presents with signs compatible with intoxication but the toxin is unidentified, how does the clinician narrow the differential diagnosis, select appropriate diagnostics, and make timely intervention decisions? The approach integrates signalment, exposure history, physical examination findings, and targeted laboratory testing. Species differences matter, and the reasoning framework accounts for the fact that dogs, cats, ruminants, and horses have markedly different toxicant exposures and metabolic responses.

At a Glance

Pathophysiology of Toxicant Exposure

Toxicants produce clinical disease through several discrete mechanisms. Direct cellular toxicity occurs when a compound or its metabolite damages cellular structures, as seen with acetaminophen-induced hepatic necrosis in cats. Receptor-mediated effects arise when a toxin mimics or blocks endogenous ligands, exemplified by organophosphate inhibition of acetylcholinesterase at synaptic junctions. Metabolic disruption occurs when a toxicant interferes with energy production, such as cyanide binding to cytochrome oxidase in the mitochondrial electron transport chain.

The route of exposure determines absorption kinetics and first-pass metabolism. Oral exposures undergo hepatic biotransformation before reaching systemic circulation, which can either activate or detoxify the parent compound. Dermal exposures bypass portal circulation but may cause significant local tissue damage before systemic absorption. Inhalational exposures reach the systemic circulation rapidly due to the large alveolar surface area and high pulmonary blood flow.

Biotransformation pathways vary substantially across species. Cats have reduced glucuronidation capacity, making them particularly susceptible to compounds that require this pathway for detoxification. Ruminants rely heavily on ruminal microbial metabolism, which can both activate and degrade toxic plant compounds. These species differences are not academic details, they determine which patients are at highest risk for specific toxicants and how quickly clinical signs develop.

Toxidrome Recognition as a Diagnostic Tool

Toxidrome recognition forms the foundation of the diagnostic approach to unknown exposures. A toxidrome is a constellation of clinical signs that suggests a particular class of toxicant. The clinician identifies the pattern, then uses it to narrow the differential list and select confirmatory diagnostics.

Sympathomimetic Toxidrome

Hyperthermia, mydriasis, tachycardia, hypertension, and agitation characterize this pattern. Common causes include amphetamines, cocaine, methylxanthines, and certain plants. The presentation overlaps with anxiety and pain, so the clinician must actively seek supporting evidence such as pupil size, heart rate trends, and temperature trajectory.

Cholinergic Toxidrome

Salivation, lacrimation, urination, defecation, vomiting, and miosis define this pattern. Organophosphate and carbamate insecticides are the classic causes. Bradycardia and muscle fasciculations distinguish this toxidrome from other causes of gastrointestinal signs. The presence of miosis is a critical differentiating feature.

Anticholinergic Toxidrome

Mydriasis, dry mucous membranes, tachycardia, urinary retention, and ileus characterize this pattern. Sources include antihistamines, atropine-containing plants, and some mushrooms. Hyperthermia may develop due to impaired sweating and panting efficiency. The absence of salivation distinguishes this from the cholinergic toxidrome.

Opioid Toxidrome

CNS depression, miosis, bradycardia, and hypoventilation define this pattern. Sources include prescription opioids, illicit drugs, and certain plants. Respiratory depression is the life-threatening component and requires immediate attention. The presence of miosis in a depressed patient is highly suggestive.

Methemoglobin-Inducing Toxidrome

Cyanosis that does not resolve with oxygen supplementation, chocolate-colored blood, and dyspnoea characterize this pattern. Acetaminophen, benzocaine, and certain plants are common causes. Pulse oximetry readings are unreliable in these patients because the device cannot distinguish oxyhemoglobin from methemoglobin.

Diagnostic Approach to the Unknown Exposure

When the toxicant is unidentified, the diagnostic plan proceeds in a logical sequence. The first priority is always patient stabilization, which follows the same principles as any emergency presentation. The RECOVER Initiative veterinary CPR guidelines provide the evidence-based framework for resuscitation when cardiovascular collapse occurs, and these protocols apply regardless of the underlying toxicant.

History and Environmental Assessment

The exposure history is the single most valuable diagnostic tool. The clinician should ask about access to medications, household chemicals, plants, and rodenticides. For livestock, pasture access, feed changes, and water sources require investigation. The USDA-ARS Poisonous Plant Research Laboratory provides resources for plant identification and toxicology consultation, and their interdisciplinary team can assist with plant-related poisonings in production animals.

History should establish the time of exposure, the amount ingested if known, and the onset of clinical signs. A short onset interval suggests a rapidly absorbed toxicant, while delayed onset may indicate a compound requiring metabolic activation. The clinician should also ask about recent medication administration, including topical products, because dermal exposures are frequently overlooked.

Physical Examination and Monitoring

The physical examination should be systematic and repeated at intervals to detect progression. Temperature, heart rate, respiratory rate, mucous membrane color, capillary refill time, and pupil size should be recorded at presentation and at regular intervals thereafter. Trends matter more than single readings. A patient with normal vital parameters at presentation may deteriorate rapidly as the toxicant is absorbed or metabolised.

Continuous ECG monitoring is indicated for any patient with suspected cardiotoxic exposure or unexplained arrhythmias. The MSD Veterinary Manual provides species-specific reference ranges and guidance on interpreting conduction disturbances, which is essential when distinguishing toxicant-induced arrhythmias from those caused by hypoxia, electrolyte imbalance, or underlying cardiac disease.

Laboratory Testing Strategy

Baseline laboratory testing should include a complete blood count, serum biochemistry profile, and urinalysis. These tests identify target organ injury and provide prognostic information. Specific testing depends on the suspected toxicant class. Coagulation testing is indicated when anticoagulant rodenticide exposure is possible, and the results guide vitamin K therapy decisions. Blood gas analysis with electrolyte measurement identifies acid-base disturbances that characterize specific toxicants, such as metabolic acidosis with ethylene glycol or respiratory alkalosis with salicylates.

Quantitative toxicology testing is available for some compounds, but results are rarely available in time to influence acute management. The clinician should therefore use toxidrome recognition and supportive laboratory findings to guide initial therapy while confirmatory testing is pending. This approach acknowledges the practical limitations of toxicology testing in emergency practice.

Fluid Therapy and Supportive Care

Fluid therapy is a central element of supportive care in toxicologic emergencies, though the specific approach varies with the toxicant and the patient's cardiovascular status. The AAHA/AAFP fluid therapy guidelines for dogs and cats provide a framework for fluid selection, rate planning, and monitoring that applies to toxicology patients. These guidelines emphasize individualised fluid plans based on patient assessment instead of formulaic dosing, which is particularly relevant when the toxicant may cause renal injury, pulmonary edema, or cardiac dysfunction.

Species-Specific Considerations

The diagnostic approach must be adapted to the species presented. Small animal practice most commonly encounters pharmaceutical exposures, household chemicals, and human food items. Production animal practice encounters plant toxicities, feed-related exposures, and agricultural chemicals. The WOAH terrestrial animal health code addresses surveillance and reporting requirements for certain toxicants that may have food safety or trade implications, and the practitioner should be aware of these obligations when managing production animal cases.

Cats require particular caution with any medication intended for dogs or humans, and their reduced glucuronidation capacity makes them vulnerable to a broader range of compounds. Ruminants may present with herd-level disease instead of individual cases, which changes the diagnostic approach from individual patient evaluation to outbreak investigation. Horses have unique sensitivities to certain plants and medications, and their large body mass complicates dose calculations for any therapeutic intervention.

The American Veterinary Medical Association practice resources provide guidance on professional obligations related to suspected poisoning cases, including documentation, client communication, and potential reporting requirements. These resources support the practitioner in managing the medicolegal aspects of toxicology cases while maintaining focus on patient care.

Structured Diagnostic Testing for Suspected Poisoning

When the toxidrome points to a specific toxicant class, targeted testing confirms the diagnosis and guides prognosis. The table below lists first-line tests, sample types, and the clinical question each test answers.

Sample handling matters. Collect gastric content before decontamination whenever possible. Store urine and serum frozen if analysis will be delayed. For anticoagulant rodenticides, draw blood before administering vitamin K1, because exogenous vitamin K normalizes clotting times within hours and obscures the diagnosis.

Decontamination Decisions

Decontamination is time-sensitive and risk-dependent. Induction of emesis is appropriate only in conscious patients with intact gag reflexes, within 2 to 4 hours of ingestion of a toxin with meaningful oral bioavailability. Contraindications include caustic agents, petroleum distillates, sharp objects, and toxins that cause rapid onset of seizures or coma. In patients with altered mentation, perform orotracheal intubation before any gastric intervention.

Activated charcoal is most useful within 1 to 2 hours of ingestion. Repeat dosing benefits toxins that undergo enterohepatic recirculation, such as some rodenticides and cardiac glycosides. Do not administer charcoal with sorbitol more than once, because repeated osmotic cathartics cause hypernatremia and dehydration. Charcoal is ineffective for alcohols, caustics, and metals.

Gastric lavage has a narrow role. Consider it only for life-threatening ingestions presenting within 1 hour, and only with airway protection. Whole-bowel irrigation is reserved for sustained-release products, body packers, or ingested packets of illicit drugs.

Species changes the risk calculus. Cats are more sensitive to the emetic effects of alpha-2 agonists and more prone to aspiration. Ruminants and horses are not candidates for emesis, orogastric intubation and rumenotomy or gastric lavage are the practical options. Production animals with suspected plant poisonings often benefit more from removal from the pasture and supportive care than from aggressive decontamination, as the USDA-ARS Poisonous Plant Research Laboratory notes in its overview of plant poisoning diagnosis and management.

Antidote Administration and Timing

Antidotes are not substitutes for decontamination or supportive care. Administer them when the toxidrome or confirmed test result justifies their use. For opioid toxidrome, naloxone is given to effect, titrated to restore ventilation instead of full consciousness. For anticholinergic toxidrome, physostigmine is reserved for severe agitation or supraventricular tachycardia with hemodynamic compromise. For methemoglobinemia, methylene blue is indicated when methemoglobin exceeds 20 to 30 percent or when clinical signs are severe.

Current formulary and label references must be consulted for doses, routes, and contraindications. Several antidotes carry species-specific warnings. Methylene blue is contraindicated in cats at standard canine doses because of Heinz body hemolysis. Naloxone is short-acting, and re-sedation occurs when the opioid outlasts the antidote. Atropine for cholinergic crisis requires frequent reassessment, because over-atropinisation produces an anticholinergic toxidrome that is harder to manage than the original crisis.

Monitoring Parameters and Escalation Criteria

Serial monitoring detects deterioration before it becomes irreversible. The following parameters and their clinical meaning guide escalation.

Cardiopulmonary arrest in poisoned patients carries a poor prognosis, but the RECOVER Initiative guidelines provide a structured approach to resuscitation that applies regardless of cause. Post-arrest care in poisoned patients should include continued toxin identification, because the cause of arrest often determines the success of ongoing treatment.

Documentation and Case Reporting

Document the exposure history, time of ingestion, estimated dose, decontamination method and timing, antidote administration, and serial monitoring values. Record the reasoning for each diagnostic and therapeutic decision. This record supports later review if the case deteriorates or if regulatory questions arise.

Report suspected malicious poisoning, foodborne outbreaks, or unusual clusters to the appropriate animal health authority. The World Organization for Animal Health terrestrial animal health standards describe surveillance and reporting obligations that may apply to production animals and notifiable diseases. Companion animal poisonings are generally not notifiable, but regional variation exists.

Photographs of the suspected plant, bait, or product label are valuable. Collect them with the owner's permission and store them with the medical record. For plant poisonings, the USDA-ARS Poisonous Plant Research Laboratory accepts samples for identification and toxicologic analysis, and its interdisciplinary team can assist with diagnostic and prognostic questions in livestock cases.

When to Refer or Transfer

Transfer to a referral center is indicated when the patient requires hemodialysis, continuous rate infusion of antidotes, mechanical ventilation, or 24-hour specialist monitoring. Examples include ethylene glycol with acute kidney injury, severe methemoglobinemia, and bromethalin intoxication with progressive neurologic signs. Regional poison control centers and veterinary toxicology services provide telephone consultation and can guide sample submission.

Referral is also appropriate when the toxicant is unknown and the patient is deteriorating despite supportive care. In these cases, the receiving facility can perform advanced diagnostics and provide higher-intensity monitoring. Communicate the toxidrome, decontamination status, antidotes given, and current vital parameters in the transfer summary.

Recognized Complications and Early Detection

The poisoned patient can deteriorate along predictable pathways, and each has an early warning signature. Hypoventilation from opioid or sedative-hypnotic toxicants produces a rising arterial carbon dioxide tension before oxygen saturation falls. Capnography detects this trend minutes before pulse oximetry changes, and the RECOVER guidelines for cardiopulmonary resuscitation emphasize that ventilation status must be assessed continuously in any patient with suspected central nervous system depression. Serial end-tidal carbon dioxide measurement is the discriminating monitor.

Cardiac arrhythmias complicate sympathomimetic and cardiotoxic exposures. Ventricular premature complexes may precede sustained ventricular tachycardia, and bradyarrhythmias can herald complete atrioventricular block in calcium channel antagonist or beta-blocker toxicosis. Continuous electrocardiography is the only reliable method for detecting these transitions. A sudden change in heart rate or rhythm, even without a palpable pulse deficit, warrants immediate rhythm strip interpretation.

Methemoglobinemia presents a specific monitoring challenge. Pulse oximetry reads falsely normal or low in a characteriztic pattern, and the measured saturation does not track clinical severity. Co-oximetry on a venous or arterial blood gas sample is the definitive check. The patient may appear cyanotic with a normal arterial oxygen tension, and the discrepancy between the two values is the diagnostic clue.

Hypoglycemia develops insidiously with xylitol, sulfonylureas, and some hepatotoxicants. Serial blood glucose measurement, not clinical observation, detects the decline. Neuroglycopenic signs such as disorientation or weakness appear late, and by then the patient may be seizing. The same principle applies to coagulopathy from anticoagulant rodenticides: a rising activated clotting time or prolonged prothrombin time precedes visible hemorrhage.

Common Errors and Corrective Actions

The most frequent error in toxicology cases is anchoring on the first plausible toxicant and ignoring contradictory data. A dog presented for chocolate ingestion with tachycardia and agitation may instead have a sympathomimetic drug exposure, and the two require different monitoring intensity. The corrective action is to maintain a differential list based on the toxidrome, not the history alone.

A second error is decontamination before stabilization. Emesis is contraindicated in a seizing, obtunded, or dysphagic patient, and the aspiration risk exceeds the benefit of gastric emptying. The MSD Veterinary Manual advises that decontamination decisions follow, not precede, assessment of airway, breathing, and circulation. Less experienced clinicians may also induce emesis after the time window for meaningful recovery has passed, exposing the patient to risk without benefit.

A third error is failure to recheck laboratory values. A single normal blood glucose or coagulation panel does not exclude a delayed effect. The antidote and monitoring plan must specify the interval for repeat testing, and the clinician should document the expected time course of the toxicant.

A fourth error is treating the toxin instead of the patient. Two animals with the same toxicant may require different support based on comorbidities, hydration status, and presenting severity. The AAHA and AAFP fluid therapy guidelines stress that fluid selection and rate must be individualised and reassessed frequently, not applied as a fixed protocol.

Troubleshooting Table

Limitations of Evidence and Divergent Expert Opinion

The toxicology literature is dominated by case reports and retrospective series, and prospective comparative data are scarce. Plant toxicoses in particular are understudied because outbreaks are sporadic and geographically dispersed. The USDA-ARS Poisonous Plant Research Laboratory provides diagnostic support and field investigation for plant-related cases, but its primary focus is livestock production, and small animal plant toxicoses are less well characterized. Extrapolation between species is often necessary but carries real risk, since metabolic pathways and receptor affinities differ.

Expert opinion diverges on several practical points. The utility of activated charcoal in late-presenting patients is contested, with some authorities advocating its use for delayed-release formulations and others limiting it to the first few hours. Gastrointestinal decontamination in asymptomatic patients is similarly debated, particularly when the toxicant is poorly adsorbed by charcoal. The threshold for inducing emesis at home versus in hospital remains a point of disagreement among veterinary toxicologists.

Referral, Consultation, and Reporting

Referral is indicated when the patient requires continuous monitoring that the practice cannot provide, when mechanical ventilation is needed, or when specialist expertise in toxicology or critical care would alter the outcome. Transfer should occur before decompensation, not after. The receiving facility needs a complete summary of the toxicant, time of exposure, treatments administered, and current monitoring parameters.

Specialist consultation is appropriate for unfamiliar toxicants, for exposures in pregnant or pediatric patients, and for cases where the toxicant is unidentified but the patient is deteriorating. Veterinary poison control services provide real-time toxicant identification and management guidance, and their involvement should be documented in the medical record.

Regulatory reporting obligations vary by jurisdiction and by toxicant. Suspected malicious poisoning, food animal residues, and reportable diseases may trigger mandatory notification. The AVMA practice resources and the WOAH terrestrial animal health standards describe the frameworks for disease reporting and international trade implications, and the clinician should know the requirements for the region in which they practice. When in doubt, contact the relevant authority before the case closes.

Frequently Asked Questions

How Do I Manage a Suspected Poisoning When Advanced Diagnostics Are Unavailable?

Prioritize toxidrome recognition and serial physical examination. A structured examination, including mentation, pupil size, mucous membrane color, heart rate, respiratory pattern, and gastrointestinal sounds, often narrows the differential list more than any single test. When laboratory confirmation is impossible, document clinical response to supportive care and antidotal trials where the risk-benefit ratio favours intervention. Contact a diagnostic laboratory or poison control service for guidance on sample collection, storage, and shipping before treatment alters results. The USDA-ARS Poisonous Plant Research Laboratory offers diagnostic assistance for plant-related intoxications, particularly in livestock, and can advise on sample handling when local testing is unavailable.

What Should I Do When Financial Constraints Limit the Diagnostic Workup?

Focus the workup on tests that directly alter immediate management. A minimum database of packed cell volume, total solids, blood glucose, and electrolyte assessment often provides sufficient direction for stabilization. Prioritize decontamination and supportive care over exhaustive testing when the suspected toxin has a predictable clinical course. Discuss the prognostic value of each additional test with the owner before performing it, and document the reasoning for any tests declined. The AAHA/AAFP fluid therapy guidelines can help you plan cost-effective supportive care by matching fluid selection and monitoring intensity to patient status instead of to a fixed protocol.

How Does the Diagnostic Approach Differ in Livestock Compared with Small Animals?

Livestock poisoning is often herd-based instead of individual, so the diagnostic unit shifts from the single patient to the group and the pasture. Examine the environment first, including feed sources, water access, and plant populations, because multiple animals affected simultaneously strongly suggests a common source. Individual animal treatment matters less than identifying and removing the exposure. The USDA-ARS Poisonous Plant Research Laboratory provides interdisciplinary expertise in plant identification, toxic compound analysis, and management strategies for range and pasture losses. Production species also carry withdrawal period considerations that do not apply to companion animals, and these must be addressed before any treatment is administered.

What Records Should I Keep for a Suspected Poisoning Case?

Document the timeline of exposure, clinical signs in chronological order, physical examination findings, treatments administered with times, and the rationale for each diagnostic decision. Record photographs of the suspected toxin, the environment, and packaging when available. Note any samples collected, their storage conditions, and the laboratory they were sent to. This documentation supports both clinical continuity and potential regulatory review. The AVMA practice resources provide guidance on medical record standards and professional obligations that apply to toxicology cases. If the case involves a food-producing animal, additional documentation may be required to support withdrawal decisions and to satisfy trade-related animal health standards.

How Do I Explain an Uncertain Diagnosis to the Owner or Herd Manager?

Be direct about what is known and what remains unknown. Distinguish between a confirmed toxin, a suspected toxin based on toxidrome, and an unknown exposure with supportive findings. Explain that treatment is directed at the clinical syndrome instead of the specific molecule, and that this approach is standard when the toxin cannot be identified. Provide a realistic prognosis based on the toxidrome and the patient's response to initial therapy. For livestock producers, frame the discussion around herd-level risk and source control. The MSD Veterinary Manual offers client-facing summaries of common intoxications that can reinforce your verbal explanation without oversimplifying the medical uncertainty.

When Should I Report a Poisoning Case to Authorities?

Reporting obligations vary by jurisdiction, toxin, and species involved. Report suspected malicious poisoning, cases involving regulated substances, and any intoxication that may affect the human food chain. Food-producing animal cases may trigger withdrawal or movement restrictions under regional animal health regulations. The WOAH terrestrial animal health standards describe international expectations for disease reporting and surveillance that may apply when a toxic event mimics a notifiable disease or affects trade. When uncertain whether reporting is required, contact your regional veterinary authority before the case closes. Document the consultation and the advice received in the medical record.

Related Clinical & Scientific Guides

• Veterinary Cardiopulmonary Resuscitation: Post-Cardiac Arrest Care
• Fluid Therapy Guidelines for Dogs and Cats: A Practical Update
• Veterinary Blood Transfusion Reactions: Recognition and Management

References and Further Reading

• The good and the bad of poisonous plants: an introduction to the USDA-ARS Poisonous Plant Research Laboratory.. 2012.
• RECOVER Initiative Veterinary CPR Guidelines. Veterinary Emergency and Critical Care Society.
• AAHA/AAFP Fluid Therapy Guidelines for Dogs and Cats. AAHA.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.
• WOAH Terrestrial Animal Health Code. WOAH.

Related Articles

• Veterinary Toxicology: Common Toxins and Emergency Management
• Recognizing and Managing Anaphylaxis in Emergency Practice
• Veterinary Emergency Medicine: Common Presentations and Triage Priorities
• Capnography in Veterinary Emergency and Critical Care
• Veterinary Electrocardiography in Emergency and Critical Care

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.